Philips and Rennes University Hospital Sign 5-Year Technology, Research and Innovation Partnership to Advance Patient Care

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Rennes University Hospital, one of France's leading hospitals in image-guided interventions, robotics and clinical research, today announced the signing of a 5-year technology and innovation partnership to support diagnostic, interventional imaging and patient monitoring and management, undertake clinical research, and leverage Philips' and Rennes University Hospital's ecosystems of open innovation to foster French start-up companies.

Philips will deliver new medical technologies and provide management and maintenance services for the hospital's diagnostic and interventional imaging modalities (MRI, CT, and image-guided therapy) as well as patient monitoring. Informatics solutions will offer central, high-resolution data capture and storage (data warehouses) to drive quality and efficiency improvements, and comprehensive visualization and analysis tools to enhance diagnostic confidence for complex medical cases. Philips Healthcare Transformation Services experts will help to optimize the hospital's clinical pathways and patient experience, especially for intensive care units (ICUs) and neuro-radiology departments.

"Philips and Rennes University Hospital are entering into a ground-breaking partnership aimed at significantly improving the stroke pathway and co-developing AI algorithms to improve care for the most acute patients, particularly those in the ICU," said David Corcos, General Manager Philips France. "Leveraging the hospital’s clinical expertise and our respective innovation ecosystems, we believe we can jointly innovate to help the hospital’s healthcare professionals improve care and outcomes for their patients, while contributing to a more sustainable healthcare system. We are thrilled by this unique opportunity."

Research and innovation

Key elements of the partnership are collaborative research and innovation activities focused on areas that combine Philips' technological expertise with Rennes University Hospital's clinical expertise. Co-development projects will focus on several key areas of joint strategic interest - optimized stroke management, robotics for neurological interventions, big data analytics and artificial intelligence (AI) for monitoring patients in ICUs, and AI algorithms to support digital pathology. In addition, the hospital will have access to Philips' in-house expertise and open-innovation ecosystem to foster the creation of French tech start-ups that can translate research into clinical solutions.

"The University Hospital of Rennes is particularly glad to join its forces with Philips in the framework of an original and ambitious partnership, unique in France, offering tremendous opportunities for innovation and co-development of new solutions to shape the future of medicine and patient care," said Véronique Anatole-Touzet, CEO at Rennes University Hospital. "This collaboration is the result of several years of fruitful collaboration. Thanks to its rich and integrated character, this partnership will be an amazing catalyst for innovation and research for the University Hospital of Rennes."

Rennes University Hospital, with more than 1,800 beds shared among 4 different sites, is one of the top 10 hospitals in France and a reference center in cardiac and vascular surgery, transplantation, next to other specialisms such as neurosurgery, neuroradiology and robotics. In terms of research and innovation, it has around 200 professionals involved in more than 1,700 research projects shared among 14 research units. Philips and Rennes University Hospital already have multiple collaborations in the field of medical imaging, plus an innovation partnership in digital pathology - the first of its kind in France. Today's strategic partnership also includes two associate partners of the University Hospital - the University of Rennes 1 and the Saint-Laurent polyclinic.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries.

Most Popular Now

AI Predicts Lung Cancer Risk

An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology. Lung cancer is...

EU Health Policy Platform Calls for Prop…

The European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is...

What Next for Social Care?

Highland Marketing's advisory board welcomed Jane Brightman, social care lead at Institute of Health and Social Care Management, to discuss the sector and its technology needs. A lot of hope...

Philips Introduces the New Spectral Comp…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed...

Web-Based System Developed to Give Care …

Black Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be...

Grand Challenge Research Harnesses AI to…

Breast cancer has recently overtaken lung cancer to become the most common cancer globally, according to the World Health Organization. Advancing the fight against breast cancer, the BreastPathQ Challenge was...

UCSF Improves Fetal Heart Defect Detecti…

UC San Francisco researchers have found a way to double doctors' accuracy in detecting the vast majority of complex fetal heart defects in utero - when interventions could either correct...

EU4Health Programme: Regulation (EU) 202…

The Programme should be a means of promoting actions in areas where there is a Union added value that can be demonstrated. Such actions should include, inter alia, strengthening...

MEDICA 2021 + COMPAMED 2021: Medical Tec…

15 - 18 November 2021, Düsseldorf, Germany. The date for the globally leading live platforms for the medical technology industry remains a fixed feature in everybody's calendar this year too. The...

New AI Technology Protects Privacy

Digital medicine is opening up entirely new possibilities. For example, it can detect tumors at an early stage. But the effectiveness of new AI algorithms depends on the quantity and...

GP use of Tech Helps Prevent Prescribing…

Academic analysis shows primary care prescribers have been preventing adverse drug reactions, harm and hospital admissions through safer prescribing, after using prescribing tech. The company behind the system also reveals...